Diagnostics

Mylab's Solutions to End Global TB Pandemic

Mylab’s innovative solutions to End TB involves faster, more accurate, and cost-effective TB detection, latent TB screening and Prevention.
* 0 Million

People were suffering from TB worldwide in 2023.

* 0 %

Of global TB cases in 2023 are from India.

* 0 Million
Lives saved by TB diagnosis and treatment
* 0 Million

Deaths were caused by TB in 2023 globally.

About Program

Tuberculosis (TB) remains a global challenge, and The WHO emphasizes the need for robust, high-quality systems with modern diagnostics for rapid and accurate TB detection. Mylab’s End TB Program addresses this urgency with a comprehensive, end-to-end solution—accelerating screening, and diagnosis. Committed to eliminating TB, Mylab empowers healthcare systems with cutting-edge technology to detect, manage, and prevent the disease, bringing us closer to a TB-free world.

Screening

TB screening detects latent and active infections early, enabling timely treatment, reducing transmission, and preventing complications. It is vital for high-risk populations and essential for global TB control.
Cy-Tb
Cy-Tb is the next-generation test for latent TB detection.
MyWave
Bronchial Drainage Airway Clearance System
MyBeam®
Safe & Convenient Medical Handheld X-Ray System

Detection

Advanced diagnostics, like Mylab’s molecular assays, enable reliable, accurate, and drug-resistant TB identification, ensuring early treatment and better disease control.
PathoDetect®
The Pathogen Detection Expert Detect infectious pathogens with ease.
Compact DX®
Complete Walkaway Sample-to-Report Automation System
Compact XL®
Powerful Sample-to-PCR ready Molecular Automation System

Treatment

The government lays standardized treatment regimen for MDR TB in India. Strict adherence to medication is crucial to prevent resistance and ensure cure.
Categories
Treatment of Tuberculosis is categorically dependent upon,
Objectives
TB treatment is provided as per the following objectives:

Prevention

TB prevention focuses on vaccination (rBCG), early detection, prompt treatment, and infection control measures.
R-BCG Vaccine
Mylab, in collaboration with the Serum Institute of India, will soon be launching the Recombinant-BCG vaccine to prevent TB infection.

MyVan®

MyVan® is Mylab’s mobile testing laboratory enabling faster diagnostic tests; on the go. MyVan®, is accredited by NABL certification. It is also validated and approved by the ICMR and the NIV.
Benefits
Mobile van
APPLY FOR THIS JOB
Are you ready for this new challenge?
Thank you for choosing us!
Our team will contact you using the details provided below at the earliest opportunity.